Cargando…

Chalcone Derivatives: Promising Starting Points for Drug Design

Medicinal chemists continue to be fascinated by chalcone derivatives because of their simple chemistry, ease of hydrogen atom manipulation, straightforward synthesis, and a variety of promising biological activities. However, chalcones have still not garnered deserved attention, especially consideri...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomes, Marcelo N., Muratov, Eugene N., Pereira, Maristela, Peixoto, Josana C., Rosseto, Lucimar P., Cravo, Pedro V. L., Andrade, Carolina H., Neves, Bruno J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152227/
https://www.ncbi.nlm.nih.gov/pubmed/28757583
http://dx.doi.org/10.3390/molecules22081210
_version_ 1783357322252255232
author Gomes, Marcelo N.
Muratov, Eugene N.
Pereira, Maristela
Peixoto, Josana C.
Rosseto, Lucimar P.
Cravo, Pedro V. L.
Andrade, Carolina H.
Neves, Bruno J.
author_facet Gomes, Marcelo N.
Muratov, Eugene N.
Pereira, Maristela
Peixoto, Josana C.
Rosseto, Lucimar P.
Cravo, Pedro V. L.
Andrade, Carolina H.
Neves, Bruno J.
author_sort Gomes, Marcelo N.
collection PubMed
description Medicinal chemists continue to be fascinated by chalcone derivatives because of their simple chemistry, ease of hydrogen atom manipulation, straightforward synthesis, and a variety of promising biological activities. However, chalcones have still not garnered deserved attention, especially considering their high potential as chemical sources for designing and developing new effective drugs. In this review, we summarize current methodological developments towards the design and synthesis of new chalcone derivatives and state-of-the-art medicinal chemistry strategies (bioisosterism, molecular hybridization, and pro-drug design). We also highlight the applicability of computer-assisted drug design approaches to chalcones and address how this may contribute to optimizing research outputs and lead to more successful and cost-effective drug discovery endeavors. Lastly, we present successful examples of the use of chalcones and suggest possible solutions to existing limitations.
format Online
Article
Text
id pubmed-6152227
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61522272018-11-13 Chalcone Derivatives: Promising Starting Points for Drug Design Gomes, Marcelo N. Muratov, Eugene N. Pereira, Maristela Peixoto, Josana C. Rosseto, Lucimar P. Cravo, Pedro V. L. Andrade, Carolina H. Neves, Bruno J. Molecules Review Medicinal chemists continue to be fascinated by chalcone derivatives because of their simple chemistry, ease of hydrogen atom manipulation, straightforward synthesis, and a variety of promising biological activities. However, chalcones have still not garnered deserved attention, especially considering their high potential as chemical sources for designing and developing new effective drugs. In this review, we summarize current methodological developments towards the design and synthesis of new chalcone derivatives and state-of-the-art medicinal chemistry strategies (bioisosterism, molecular hybridization, and pro-drug design). We also highlight the applicability of computer-assisted drug design approaches to chalcones and address how this may contribute to optimizing research outputs and lead to more successful and cost-effective drug discovery endeavors. Lastly, we present successful examples of the use of chalcones and suggest possible solutions to existing limitations. MDPI 2017-07-25 /pmc/articles/PMC6152227/ /pubmed/28757583 http://dx.doi.org/10.3390/molecules22081210 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Gomes, Marcelo N.
Muratov, Eugene N.
Pereira, Maristela
Peixoto, Josana C.
Rosseto, Lucimar P.
Cravo, Pedro V. L.
Andrade, Carolina H.
Neves, Bruno J.
Chalcone Derivatives: Promising Starting Points for Drug Design
title Chalcone Derivatives: Promising Starting Points for Drug Design
title_full Chalcone Derivatives: Promising Starting Points for Drug Design
title_fullStr Chalcone Derivatives: Promising Starting Points for Drug Design
title_full_unstemmed Chalcone Derivatives: Promising Starting Points for Drug Design
title_short Chalcone Derivatives: Promising Starting Points for Drug Design
title_sort chalcone derivatives: promising starting points for drug design
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152227/
https://www.ncbi.nlm.nih.gov/pubmed/28757583
http://dx.doi.org/10.3390/molecules22081210
work_keys_str_mv AT gomesmarcelon chalconederivativespromisingstartingpointsfordrugdesign
AT muratoveugenen chalconederivativespromisingstartingpointsfordrugdesign
AT pereiramaristela chalconederivativespromisingstartingpointsfordrugdesign
AT peixotojosanac chalconederivativespromisingstartingpointsfordrugdesign
AT rossetolucimarp chalconederivativespromisingstartingpointsfordrugdesign
AT cravopedrovl chalconederivativespromisingstartingpointsfordrugdesign
AT andradecarolinah chalconederivativespromisingstartingpointsfordrugdesign
AT nevesbrunoj chalconederivativespromisingstartingpointsfordrugdesign